Renalytix plc Quarterly Common Stock, Value, Issued in USD from Q2 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary
Renalytix plc quarterly Common Stock, Value, Issued history and growth rate from Q2 2018 to Q1 2024.
  • Renalytix plc Common Stock, Value, Issued for the quarter ending March 31, 2024 was $368K, a 28.7% increase year-over-year.
Common Stock, Value, Issued, Quarterly (USD)
Common Stock, Value, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $368K +$82K +28.7% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $305K +$76K +33.2% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 $290K +$61K +26.6% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $286K +$58K +25.4% Jun 30, 2023 10-Q 2024-05-15
Q1 2023 $286K +$66K +30% Mar 31, 2023 6-K 2023-06-09
Q4 2022 $229K +$9K +4.09% Dec 31, 2022 6-K 2023-03-30
Q3 2022 $229K Sep 30, 2022 6-K 2022-11-30
Q2 2022 $228K +$8K +3.64% Jun 30, 2022 10-K 2023-09-28
Q1 2022 $220K Mar 31, 2022 6-K 2022-06-30
Q4 2021 $220K Dec 31, 2021 6-K/A 2022-04-29
Q2 2021 $220K +$41K +22.9% Jun 30, 2021 20-F 2022-10-31
Q2 2020 $179K +$17K +10.5% Jun 30, 2020 20-F/A 2022-08-01
Q2 2019 $162K +$96K +145% Jun 30, 2019 20-F/A 2022-08-01
Q2 2018 $66K Jun 30, 2018 20-F/A 2020-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.